Natco Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "NATCO announces the Launch of additional strengths for the Generic Version of Revlimid�� (lenalidomide capsules), in the USA".
Natco Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "NATCO announces the Launch of additional strengths for the Generic Version of Revlimid�� (lenalidomide capsules), in the USA".